Table 3.
Number of patients with ACC | PET Tracer | Results | |
---|---|---|---|
Kim et al [64] | 34 | 18F-FDG | Pre-treatment SUVmax of the primary tumor is an independent prognostic factor in patients with ACC of the head and neck |
Jung JH et al [66] | 40 | 18F-FDG | 18F-FDG PET/CT showed comparable sensitivity to conventional CT and SUVmax and TLG were significant prognostic factors |
Tomura et al [65] | 27 head-neck (5 ACC) | 18F-FDG vs 11C MET | MET-PET/CT showed superior inter-rater agreement and had higher uptake for tumors at the skull base than FDG-PET/CT |
Lindoholm et al [73] | 39 SCC | 11C MET | MET PET/CT imaging is effective in SCC in head and necK |
Nuutient et al [74] | 15 SCC | 11C MET | No significance to predict the response to RT |
Hasebe et al [75] | 26 | 11C MET | TNR in CIRT is an independent factor for predicting local recurrence, the incidence of metastasis, and the prognosis |
Toubaru et al [76] | 67 | 11C MET | The TNRpre was significantly related to the occurrence of metastasis and the disease-specific survival after CIRT TNRpost was a factor that was significantly related to the development of local recurrence as well |
Hasabe et al [77] | 85 head-neck malignant melanoma | 11C MET | MET-PET/CT is useful for predicting the outcomes of patients with head and neck mucosal malignant melanoma treated with CIRT |
Klein Nulent et al [80] | 9 | 68Ga PMSA | PSMA PET/CT is able to detect and visualize local recurrent and distant metastatic disease |
Abbreviations: SCC, squamous cell carcinoma. TNR, tumor-to-normal ratio.